Latest Articles

Publication Date
Absci Announces First Participants Dosed in Phase 1/2a - GlobeNewswire

Absci Announces First Participants Dosed in Phase 1/2a GlobeNewswire

Published: Dec. 4, 2025, 1 p.m.
Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study - Citeline News & Insights

Bayer Aims To Broaden Mirena’s Use With Phase III Endometrial Hyperplasia Study Citeline News & Insights

Published: Dec. 4, 2025, 11:19 a.m.
Marquis Who's Who Honors Elham Neisani Samani, MD, for Excellence in Health Care - 24-7 Press Release

Marquis Who's Who Honors Elham Neisani Samani, MD, for Excellence in Health Care 24-7 Press Release

Published: Dec. 4, 2025, 8:36 a.m.
Scots woman demands change after 'losing organs' to 'cruel' disease - MSN

Scots woman demands change after 'losing organs' to 'cruel' disease MSN

Published: Dec. 4, 2025, 12:47 a.m.
RETRACTED ARTICLE: Effects of Kuntai capsule on breast pain and vaginal bleeding in postmenopausal women.

Description Following a complaint and technical (editorial) investigation, the authors were requested to provide essential documentation to verify the reliability, validity, and ethical compliance of the study published. Despite repeated …

Published: Dec. 4, 2025, midnight
Diagnostic performance of the #Enzian classification via ultrasound compared to laparoscopic findings in endometriosis: a retrospective cohort study.

To assess the diagnostic performance of the ultrasound-based #Enzian classification in comparison with laparoscopic surgical findings in patients with endometriosis.

Published: Dec. 4, 2025, midnight
Expanding the genetic landscape of endometriosis: Integrative -omics analyses implicate key genes and pathways in a multi-ancestry study of over one million women.

We report the findings of a genome-wide association study (GWAS) meta-analysis of endometriosis across 14 biobanks worldwide, including 32% non-European patient participants, as part of ​the ​Global Biobank Meta-Analys​i​s Initiative​ …

Published: Dec. 4, 2025, midnight
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - BioSpace

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia BioSpace

Published: Dec. 3, 2025, 2:11 p.m.
Post-Cesarean Surgical Scar Endometriosis: A Case Study and Clinical Insights from Somalia - Dove Medical Press

Post-Cesarean Surgical Scar Endometriosis: A Case Study and Clinical Insights from Somalia Dove Medical Press

Published: Dec. 3, 2025, 8:34 a.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - sharewise.com

Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia sharewise.com

Published: Dec. 3, 2025, 5:04 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!